A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS. (Gut, 2015)

(untitled) - Rosmarin, D; Palles, C; Pagnamenta, A; Kaur, K; Pita, G; Martin, M; Domingo, E; Jones, A; Howarth, K; Freeman-Mills, L; Johnstone, E; Wang, H; et al.